hrp0097p1-519 | Growth and Syndromes | ESPE2023

Evaluation of Cognitive Profiles in a cohort of patients with Turner Syndrome.

Casalini Emilio , De Mori Letizia , Angelelli Alessia , Fava Daniela , Patti Giuseppa , Napoli Flavia , Elsa Maria Allegri Anna , Gastaldi Roberto , Tedesco Caterina , Passarella Tommaso , Pistorio Angela , Di Iorgi Natascia , Maghnie Mohamad

Background: Turner Syndrome (TS) is a chromosomopathy affecting 1 out of 2000-2500 live births. Although short stature, heart disease and ovarian dysgenesis are the best-known features, patients have variable cognitive impairments. Aim of this study is to analyze the cognitive profile of a cohort of patients enrolled between February 2018-March 2023.Methods: 49 TS patients [Group A: 45, X0 (n=13); Group B: mosai...

hrp0097p1-345 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

45 mg Subcutaneous Leuprolide Acetate Suppressed Unstimulated Luteinizing Hormone (LH) to Prepubertal Concentrations

Miller Bradley , Boldt-Houle Deborah , Daugherty Rhea , Atkinson Stuart

Background: There is evidence that unstimulated LH concentrations may be appropriate to monitor hormone suppression in children with central precocious puberty (CPP) during treatment with gonadotropin-releasing hormone agonists (GnRHa). Literature suggests that unstimulated LH concentrations <0.3 and >0.8 IU/L are prepubertal and clearly pubertal, respectively. We present secondary analyses of unstimulated LH suppression data from the pivotal trial of th...

hrp0097p1-187 | Thyroid | ESPE2023

Thyroid nodules and differentiated thyroid carcinoma in children and adolescents. Experience of a tertiary pediatric endocrinology center in Greece.

Dikaiakou Eirini , Leka Sofia , Kosteria Ioanna , Athanasouli Fani , Vakaki Marina , Geli Myrsini , Sevaslidou Ioanna , Papadopoulou Katerina , Vlachopapadopoulou Elpis-Athina

Objectives: The aim of this study was to report on the frequency and describe the clinical characteristics of the ones diagnosed as thyroid cancer among all suspicious nodules diagnosed in the pediatric endocrinology department and to compare the findings with recent published literature.Methods: Retrospective study during the last 5 years. Patients aged <18 years, with suspected thyroid nodule malignancy, according t...

hrp0097p2-112 | Fat, Metabolism and Obesity | ESPE2023

Evaluation of Triglycerides to High Density Lipoprotein Cholesterol Ratio (TG/HDL-C) as a Predictor of Insulin Resistance among Obese Children and Adolescents, single center experience.

Fawaz Lubna , Abdelmoneim Mohamed , Abdel salam Reda , Shamma Radwa

Key words: Insulin resistance, triglycerides to high-density lipoprotein cholesterol-(HDL-C), HOMA-IR.Background: Childhood Obesity is a chronic metabolic disease. The fundamental disorder related to obesity is Insulin Resistance (IR). The gold standard method to measure IR is by use the hyper insulinemic euglycemic clamp, rarely performed in children because of its invasiveness, complexity, time consumption and high cos...

hrp0097p2-227 | GH and IGFs | ESPE2023

Study of different anthropometric factors on the patients with growth hormone deficiency before and after treatment

Razzaghy-Azar Maryam , Molaei Ziba

Background: Growth hormone deficiency (GHD) is one of the main endocrine disorders causing short stature. It may be due to isolated growth hormone deficiency (IGHD) or associated with multiple pituitary hormone deficiency (MPHD). The aim of this study was evaluation of anthropometric factors before and after growth hormone (GH) therapy.Patients and method: This is a historical cohort study. The diagnosis of GHD in childr...

hrp0097p2-256 | Late Breaking | ESPE2023

Influencing Factors of Growth Hormone Treatment in Short Stature Children Born Small for Gestational Age in China: a single-center, cross-sectional survey

Cheng Ruoqian , Sun Chengjun , Wu Jing , Xu Zhenran , Ni Jinwen , Xi Li , Li Xiaojing , Luo* Feihong

Keywords: growth hormone, small for gestational age, genetic defects; Silver-Russell syndrome; growth hormone deficiencyObjectives: To evaluate the influencing factors of GH treatment in Chinese short stature children born SGA.Methods: This was a single-center, retrospective, cross-sectional survey in China. Of 101 patients were identified born SGA and 66 short stature children bor...

hrp0097p2-313 | Late Breaking | ESPE2023

Oral Benfotiamine 300 mg Versus Intramuscular Thiamine in Diabetic Patients with Peripheral Neuropathy

Hesham El Hefnawy Mohamed , Ramadan Heba , effat Abanob

Keywords: Benfotiamine, Bioavailability, Thiamine, Diabetic Peripheral Neuropathy Abbreviations: Adverse Event (AE), Advanced Glycation End products (AGE), Analysis of Variance (ANOVA), Alanine Transaminase (ALT), Body Mass Index (BMI), Case Report Form (CRF), Diabetic Neuropathic Symptom score (DNSS), Diacylglycerol (DAG), Dipeptidyl Peptidase 4 Inhibitor (DPP-4 I), Good Clinical Practice (GCP), Informed Consent Form (ICF), Intent to Treat (ITT), Institutiona...

hrp0098fc2.6 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment

Mohnike Klaus , Eibenstein Ursula , Pimenta Jeanne , Reichert Anja , Mukherjee Swati , Gausche Ruth , Beger Christoph , Pfäffle Roland

Background: CrescNet is a European pseudonymous paediatric registry of longitudinal measurements used to screen for growth disorders including achondroplasia (ACH). ACH is a rare genetic condition caused by a gain-of-function variant in the fibroblast growth factor receptor 3 (FGFR3) gene, resulting in severe disproportionate short stature and medical complications related to impaired endochondral bone growth. Vosoritide (C-type natriuretic peptide analogue) i...

hrp0098fc6.4 | Fat, Metabolism and Obesity 1 | ESPE2024

Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome

Bridges Nicola , Gevers Evelien , Yanovski Jack , Salehi Parisa , Hall Shoemaker Ashley , Abuzzahab Jennifer , Obrynba Kathryn , Fleischman Amy , Stevenson David , Wilding John , Mathew Verghese , Viskochil David , Felner Eric , E. McCandless Shawn , Bird Lynne , Lah Melissa , Littlejohn Elizabeth , Shea Heidi , Holland Anthony , Goldstone Anthony , Barrett Timothy , Konczal Laura , Dharmaraj Poonam , Das Urmi , Angulo Moris , Kimonis Virginia , Guftar Shaikh Mohomad , Mejia-Corletto Jorge , Yen Kristen , Gandhi Raj , Ballal Shaila , Hirano Patricia , Cowen Neil , Bhatnagar Anish , Huang Michael , Butler Merlin , Miller Jennifer

Background: Prader-Willi syndrome (PWS) is a rare genetic neurobehavioral-metabolic disorder characterized by hyperphagia and behavioral/psychological complications. With no approved therapies to treat hyperphagia, disease management requires strict dietary and environmental controls to restrict access to food. DCCR is an oral, once-daily medication currently under development for the treatment of PWS.Objective: The obje...

hrp0098fc14.2 | Fetal and Neonatal Endocrinology | ESPE2024

Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism.

Siersbaek Julie , Soegaard Hansen Rasmus , Nybo Mads , thybo Christesen henrik

Background: Normal neonates exhibit a transitional state of physiological hyperinsulinism (HI) during the first 2-3 days of life as an adaption from the fetal state. Prolonged, pathological HI can cause irreversible cerebral damage, if not avoided by early diagnosis and prompt treatment. We hypothesized that umbilical cord blood glucose, included in routine cord gas analysis, can be used as an ideal screening tool for pathological HI. We first aimed to establi...